These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36932675)

  • 1. Preclinical evaluation of ADVM-062, a novel intravitreal gene therapy vector for the treatment of blue cone monochromacy.
    Hanna K; Nieves J; Dowd C; Bender KO; Sharma P; Singh B; Renz M; Ver Hoeve JN; Cepeda D; Gelfman CM; Riley BE; Grishanin RN
    Mol Ther; 2023 Jul; 31(7):2014-2027. PubMed ID: 36932675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy in
    Ma X; Sechrest ER; Fajardo D; Zhu P; Dyka F; Wang Y; Lobanova E; Boye SE; Baehr W; Deng WT
    Hum Gene Ther; 2022 Jul; 33(13-14):708-718. PubMed ID: 35272502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.
    Deng WT; Li J; Zhu P; Chiodo VA; Smith WC; Freedman B; Baehr W; Pang J; Hauswirth WW
    Mol Vis; 2018; 24():17-28. PubMed ID: 29386880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.
    Zhang Y; Deng WT; Du W; Zhu P; Li J; Xu F; Sun J; Gerstner CD; Baehr W; Boye SL; Zhao C; Hauswirth WW; Pang JJ
    Sci Rep; 2017 Jul; 7(1):6690. PubMed ID: 28751656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy.
    Cideciyan AV; Roman AJ; Warner RL; Sumaroka A; Wu V; Jiang YY; Swider M; Garafalo AV; Viarbitskaya I; Russell RC; Kohl S; Wissinger B; Ripamonti C; Barbur JL; Bach M; Carroll J; Morgan JIW; Aleman TS
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39408969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy.
    Cideciyan AV; Hufnagel RB; Carroll J; Sumaroka A; Luo X; Schwartz SB; Dubra A; Land M; Michaelides M; Gardner JC; Hardcastle AJ; Moore AT; Sisk RA; Ahmed ZM; Kohl S; Wissinger B; Jacobson SG
    Hum Gene Ther; 2013 Dec; 24(12):993-1006. PubMed ID: 24067079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blue cone monochromacy and gene therapy.
    Sechrest ER; Chmelik K; Tan WD; Deng WT
    Vision Res; 2023 Jul; 208():108221. PubMed ID: 37001420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.
    Luo X; Cideciyan AV; Iannaccone A; Roman AJ; Ditta LC; Jennings BJ; Yatsenko SA; Sheplock R; Sumaroka A; Swider M; Schwartz SB; Wissinger B; Kohl S; Jacobson SG
    PLoS One; 2015; 10(4):e0125700. PubMed ID: 25909963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.
    Glushakova LG; Timmers AM; Pang J; Teusner JT; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3505-13. PubMed ID: 16877422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.
    Komáromy AM; Alexander JJ; Cooper AE; Chiodo VA; Glushakova LG; Acland GM; Hauswirth WW; Aguirre GD
    Gene Ther; 2008 Jul; 15(14):1049-55. PubMed ID: 18337838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.
    Deng WT; Li J; Zhu P; Freedman B; Smith WC; Baehr W; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3644-3651. PubMed ID: 31469404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.
    Ye GJ; Budzynski E; Sonnentag P; Nork TM; Sheibani N; Gurel Z; Boye SL; Peterson JJ; Boye SE; Hauswirth WW; Chulay JD
    Hum Gene Ther; 2016 Jan; 27(1):72-82. PubMed ID: 26603570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-Mediated Gene Delivery to Foveal Cones.
    Bertin S; Brazhnikova E; Jaillard C; Sahel JA; Dalkara D
    Methods Mol Biol; 2020; 2173():101-112. PubMed ID: 32651912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cone-specific expression using a human red opsin promoter in recombinant AAV.
    Li Q; Timmers AM; Guy J; Pang J; Hauswirth WW
    Vision Res; 2008 Feb; 48(3):332-8. PubMed ID: 17905404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal cone photoreceptors of the deer mouse Peromyscus maniculatus: development, topography, opsin expression and spectral tuning.
    Arbogast P; Glösmann M; Peichl L
    PLoS One; 2013; 8(11):e80910. PubMed ID: 24260509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of opsin expression and apoptosis in determination of cone types in human retina.
    Cornish EE; Xiao M; Yang Z; Provis JM; Hendrickson AE
    Exp Eye Res; 2004 Jun; 78(6):1143-54. PubMed ID: 15109921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 73,128 bp de novo deletion encompassing the OPN1LW/OPN1MW gene cluster in sporadic Blue Cone Monochromacy: a case report.
    Buena-Atienza E; Nasser F; Kohl S; Wissinger B
    BMC Med Genet; 2018 Jun; 19(1):107. PubMed ID: 29940872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial and temporal expression of short, long/medium, or both opsins in human fetal cones.
    Xiao M; Hendrickson A
    J Comp Neurol; 2000 Oct; 425(4):545-59. PubMed ID: 10975879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and allogeneic transplantation of a novel transgenic cone-rich donor mouse line.
    Liu YV; Teng D; Konar GJ; Agakishiev D; Biggs-Garcia A; Harris-Bookman S; McNally MM; Garzon C; Sastry S; Singh MS
    Exp Eye Res; 2021 Sep; 210():108715. PubMed ID: 34343570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.
    Kiss S; Grishanin R; Nguyen A; Rosario R; Greengard JS; Nieves J; Gelfman CM; Gasmi M
    Mol Ther Methods Clin Dev; 2020 Sep; 18():345-353. PubMed ID: 32671137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.